Patents by Inventor Edi Topic

Edi Topic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF LORLATINIB AND THEIR PREPARATION
    Publication number: 20210163498
    Abstract: The present disclosure relates to Lorlatinib solid state forms, Lorlatinib salts and solid states thereof, processes for preparation thereof, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: April 19, 2019
    Publication date: June 3, 2021
    Inventors: Maja Matanovic Skugor, Ivica Grebenar, Nea Baus Topic, Dijana Skalec Samec, Edi Topic
  • SOLID STATE FORMS OF NERATINIB AND SALTS THEREOF
    Publication number: 20200308141
    Abstract: Solid state forms of Neratinib and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof are disclosed.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 1, 2020
    Inventors: Igor AVDEJEV, Edi TOPIC, Dijana Skalec SAMEC, Lidija LERMAN, Vitomir VUSAK
  • SOLID STATE FORMS OF TRISODIUM VALSARTAN: SACUBITRIL
    Publication number: 20200277266
    Abstract: Solid state forms of trisodium valsartan:sacubitril, processes for their preparation, pharmaceutical compositions containing such solid state forms and treatment methods using the pharmaceutical compositions are described.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 3, 2020
    Inventors: Edislav Leksic, Dijana Skalec Samec, Damir Sahnic, Dejan Kisicek, Martina Hrkovac, Edi Topic
  • Solid state forms of trisodium valsartan: sacubitril
    Patent number: 10689352
    Abstract: Solid state forms of trisodium vaisartan:sacubitril, processes for their preparation, pharmaceutical compositions containing such solid state forms and treatment methods using the pharmaceutical compositions are described.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: June 23, 2020
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Edislav Leksic, Dijana Skalec Samec, Damir Sahnic, Dejan Kisicek, Martina Hrkovac, Edi Topic
  • Solid state forms of Nilotinib salts
    Patent number: 10640487
    Abstract: The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: May 5, 2020
    Assignee: Teva Pharmaceuticals USA, Inc.
    Inventors: Helena Ceric, Igor Avdejev, Edi Topic
  • SOLID STATE FORMS OF NILOTINIB SALTS
    Publication number: 20190071426
    Abstract: The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: March 13, 2017
    Publication date: March 7, 2019
    Inventors: Helena CERIC, Igor AVDEJEV, Edi TOPIC
  • SOLID STATE FORMS OF TRISODIUM VALSARTAN: SACUBITRIL
    Publication number: 20180155300
    Abstract: Solid state forms of trisodium vaisartan:sacubitril, processes for their preparation, pharmaceutical compositions containing such solid state forms and treatment methods using the pharmaceutical compositions are described.
    Type: Application
    Filed: June 10, 2016
    Publication date: June 7, 2018
    Inventors: Edislav Leksic, Dijana Skalec Samec, Damir Sahnic, Dejan Kisicek, Martina Hrkovac, Edi Topic